摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl-tridecylammonium chloride

中文名称
——
中文别名
——
英文名称
methyl-tridecylammonium chloride
英文别名
tridecylmethylammonium chloride;(methyl)(tridecyl)amine hydrochloride;Methyltridecylamine hydrochloride;methyl tridecyl-ammonium chloride;methyltridecyl-ammonium chloride;methyltridecylammonium chloride;N-methyltridecan-1-amine;hydrochloride
methyl-tridecylammonium chloride化学式
CAS
——
化学式
C14H31N*ClH
mdl
——
分子量
249.868
InChiKey
YQRNTVUSJHYLNZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.49
  • 重原子数:
    16
  • 可旋转键数:
    12
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    16.6
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • ALKALI-DEVELOPABLE PHOTOSENSITIVE RESIN COMPOSITION AND BETA-DIKETONE COMPOUND
    申请人:Yamada Takashi
    公开号:US20100129753A1
    公开(公告)日:2010-05-27
    An alkali developable photosensitive resin composition contains (J) a photopolymerizable unsaturated compound having a structure resulting from the addition reaction of (B) a compound having a β-diketone moiety or a compound having a β-ketoester group to the (meth)acryloyl group of (A) a compound having at least two (meth)acryloyl groups and a hydroxyl group and subsequent esterification of the hydroxyl group of the resulting addition product with (C) a polybasic acid anhydride. The compound having a β-diketone moiety is preferably a novel β-diketone compound represented by general formula (I): wherein R 1 is a C1-C20 alkyl group; R 2 represents R 11 , OR 11 , COR 11 , SR 11 , CONR 12 R 13 , or CN; R 11 , R 12 , and R 13 are each hydrogen, a C1-C20 alkyl group, etc.; a is 0 to 3; and b is 0 to 4.
    一种可由碱显影的光敏树脂组合物,含有(J)一种光聚合不饱和化合物,该化合物的结构是由(B)含β-二酮基团或含β-酮酯基团的化合物与(A)含至少两个(甲基)丙烯酰基团和一个羟基的化合物中的(甲基)丙烯酰基团发生加成反应,并随后将所得加成产物的羟基与(C)多元酸酐进行酯化反应得到的。含β-二酮基团的化合物最好是表示为通用公式(I)的一种新型β-二酮化合物:其中R1是C1-C20烷基团;R2代表R11、OR11、COR11、SR11、CONR12R13或CN;R11、R12和R13分别是氢、C1-C20烷基团等;a是0到3;b是0到4。
  • [EN] SYNTHETIC INTERMEDIATE OF OXAZOLE COMPOUND AND METHOD FOR PRODUCING THE SAME<br/>[FR] INTERMÉDIAIRE SYNTHÉTIQUE D'UN COMPOSÉ OXAZOLE ET PROCÉDÉ DE PRODUCTION ASSOCIÉ
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2011093529A1
    公开(公告)日:2011-08-04
    An object of the present invention is to provide a method for producing an oxazole compound in a high yield. The object can be achieved by a compound represented by Formula (11): wherein R1 is a hydrogen atom or lower-alkyl group; R2 is a 1-piperidyl group substituted at the 4-position with a substituent selected from (A1a) a phenoxy group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups, (A1b) a phenoxy-substituted lower-alkyl group substituted on the phenyl moiety with one or more halogen-substituted lower-alkyl groups, (A1c) a phenyl-substituted lower-alkoxy lower-alkyl group substituted on the phenyl moiety with halogen, (A1d) a phenyl-substituted lower-alkyl group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups, (A1e) an amino group substituted with a phenyl group substituted with one or more halogen-substituted lower-alkoxy groups, and a lower-alkyl group, and (A1f) a phenyl-substituted lower-alkoxy group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups; n is an integer from 1 to 6; and X3 is an organic sulfonyloxy group.
    本发明的目的是提供一种高产率生产噁唑化合物的方法。该目的可以通过由式(11)表示的化合物实现:其中R1是氢原子或较低的烷基基团;R2是在4-位被取代的1-哌啶基团,所述取代基选自(A1a)苯氧基在苯基上取代一个或多个卤素取代的较低烷氧基团,(A1b)苯氧基取代的较低烷基基团在苯基上取代一个或多个卤素取代的较低烷基基团,(A1c)苯基取代的较低烷氧基较低烷基基团在苯基上取代卤素,(A1d)苯基取代的较低烷基基团在苯基上取代一个或多个卤素取代的较低烷氧基团,(A1e)氨基取代的苯基取代一个或多个卤素取代的较低烷氧基团和较低烷基基团,以及(A1f)苯基取代的较低烷氧基团在苯基上取代一个或多个卤素取代的较低烷氧基团;n是1到6之间的整数;X3是有机磺酰氧基团。
  • Method for preparing analogue of vitamin D
    申请人:Ng Siong Chze
    公开号:US20070088007A1
    公开(公告)日:2007-04-19
    A method for preparing analogues of C1,C24-dihydroxy-vitamin D is disclosed. Especially the method for preparing calcipotriol and tacalcitol from a starting material of Vitamin D2 is disclosed here. Calcipotriol (compound 1(a)) and tacalcitol (compound 1(b)) can be synthesized by the method of the present invention. Moreover, only nine steps are needed for the synthesis of calcipotriol using the method. Likewise, only ten steps are needed for the synthesis of tacalcitol by the present method. Hence, the present method, with less process steps and higher yields, represents an improvement over the conventional methods.
    揭示了一种制备C1,C24-二羟基维生素D类似物的方法。特别是在这里揭示了从维生素D2起始物质制备钙醇和他卡尔西醇的方法。钙醇(化合物1(a))和他卡尔西醇(化合物1(b))可以通过本发明的方法合成。此外,使用该方法合成钙醇只需要九个步骤。同样,使用本方法合成他卡尔西醇只需要十个步骤。因此,本方法具有更少的工艺步骤和更高的产量,相对于传统方法而言,代表了一种改进。
  • PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF
    申请人:Unichem Laboratories Limited
    公开号:US20170015663A1
    公开(公告)日:2017-01-19
    The present invention refers to novel process for the preparation of Apixaban. Further, the invention also related to a process for the preparation of intermediate of Apixaban from very basic and cheap row material i.e. Aniline which is widely commercially available. The present invention provides process for preparation of Apixaban using a different sequence of synthetic steps and does not involve use of Ullmann reaction.
    该发明涉及一种新型的阿匹沙班制备工艺。此外,该发明还涉及一种从非常基本和廉价的原料苯胺(广泛商业可获得)制备阿匹沙班中间体的工艺。该发明提供了一种使用不同合成步骤顺序制备阿匹沙班的工艺,并且不涉及乌尔曼反应的使用。
  • PROCESS FOR PREPARING DIALKYL THIODIGLYCOLATES
    申请人:Rodefeld Lars
    公开号:US20090163736A1
    公开(公告)日:2009-06-25
    A process is described for preparing alkyl thiodiglycolates of the general formula (I) R—OOC—CH2-S—CH2-COO—R   (I) where R is a radical of branched or unbranched C 1 to C 10 -alkyl, characterized in that an alkyl haloacetate of the general formula (II) X—CH2-COO—R   (II) where X is a chlorine or bromine atom and R is as defined for compounds of the formula (I) is reacted with an aqueous solution of alkali metal sulphide or alkali metal hydrogensulphide in the presence of an aqueous pH buffer solution in the pH range between 5 and 8, optionally in the presence of a phase transfer catalyst.
    描述了一种制备通式(I)R—OOC—CH2-S—CH2-COO—R的烷基硫代乙酸酯的方法,其中R是支链或直链C1到C10烷基的基团,其特征在于将通式(II)X—CH2-COO—R的烷基卤代乙酸酯(II)(其中X是氯或溴原子,R如通式(I)中化合物所定义)与碱金属硫化物或碱金属氢硫化物的水溶液在水相pH缓冲溶液的存在下在pH值在5到8之间的范围内反应,可选地在存在相转移催化剂的情况下。
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰